Inferior vena cava filters have emerged as a popular tool to reduce risk for pulmonary embolism. Nevertheless, their use can be a polarizing issue among physicians. “Many physicians would say that ...
Abstract: Global Inferior Vena Cava (IVC) Filters Market to Reach $1. 1 Billion by 2026 . - Inferior vena cava filters are vascular filters intended to be implanted into inferior vena cava for ...
Despite clinical trial data showing inferior vena cava (IVC) filters are ineffective for reducing mortality following deep vein thrombosis (DVT), as well as guideline recommendations against their use ...
Plaintiffs who brought thousands of lawsuits over IVC, or inferior vena cava, filters got off to a rough start on Thursday when a federal jury came out with a defense verdict in the first trial over ...
The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...
Prophylactic inferior vena cava filter placement declined in the United States from 2005 to 2014, but rates varied by geography, according to a research letter published in JAMA Internal Medicine. The ...
The latest study to tackle the safety and efficacy of inferior vena cava (IVC) filters—this time in trauma patients—has found no benefit of device insertion in reducing symptomatic pulmonary embolism ...
August 11, 2010 (Rockville, Maryland and York, Pennsylvania) — The Food and Drug Administration (FDA) has received more than 900 reports of adverse events with inferior vena cava (IVC) filters, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback